INTERCEPT PHARMACEUTICALS IN's ticker is ICPT and the CUSIP is 45845P108. A total of 157 filers reported holding INTERCEPT PHARMACEUTICALS IN in Q3 2023. The put-call ratio across all filers is 2.78 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $995,487 | +17.4% | 53,694 | -30.0% | 0.00% | 0.0% |
Q2 2023 | $847,893 | +4.2% | 76,663 | +26.6% | 0.00% | 0.0% |
Q1 2023 | $813,375 | +305.1% | 60,564 | +273.2% | 0.00% | – |
Q4 2022 | $200,765 | -82.9% | 16,230 | -80.7% | 0.00% | -100.0% |
Q3 2022 | $1,174,000 | +29.6% | 84,141 | +51.1% | 0.00% | +100.0% |
Q1 2022 | $906,000 | +271.3% | 55,700 | +272.3% | 0.00% | – |
Q4 2021 | $244,000 | +1933.3% | 14,963 | +14863.0% | 0.00% | – |
Q4 2019 | $12,000 | -99.7% | 100 | -99.8% | 0.00% | -100.0% |
Q3 2019 | $3,544,000 | +229.7% | 53,400 | +316.8% | 0.03% | +222.2% |
Q2 2018 | $1,075,000 | -28.5% | 12,812 | -47.6% | 0.01% | -40.0% |
Q1 2018 | $1,504,000 | +27.1% | 24,444 | +20.7% | 0.02% | +87.5% |
Q4 2017 | $1,183,000 | +33.4% | 20,251 | +32.6% | 0.01% | 0.0% |
Q3 2017 | $887,000 | +74.3% | 15,278 | +263.4% | 0.01% | +60.0% |
Q2 2017 | $509,000 | -45.7% | 4,204 | -49.2% | 0.01% | -54.5% |
Q1 2017 | $937,000 | +73.5% | 8,282 | +66.8% | 0.01% | +120.0% |
Q4 2016 | $540,000 | +2.3% | 4,966 | +54.8% | 0.01% | -16.7% |
Q3 2016 | $528,000 | +41.9% | 3,208 | +23.0% | 0.01% | +50.0% |
Q2 2016 | $372,000 | +1.6% | 2,608 | +6.5% | 0.00% | 0.0% |
Q4 2015 | $366,000 | +1364.0% | 2,448 | +1521.2% | 0.00% | – |
Q3 2015 | $25,000 | -94.3% | 151 | -91.8% | 0.00% | -100.0% |
Q2 2015 | $442,000 | -87.7% | 1,831 | -85.7% | 0.01% | -89.5% |
Q1 2015 | $3,605,000 | +2020.6% | 12,784 | +1683.0% | 0.06% | +1800.0% |
Q3 2014 | $170,000 | -86.0% | 717 | -80.5% | 0.00% | -85.0% |
Q1 2014 | $1,211,000 | – | 3,671 | – | 0.02% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Sarissa Capital Management LP | 635,300 | $53,308,000 | 10.69% |
Senvest Management, LLC | 976,127 | $81,907,000 | 5.65% |
Melqart Asset Management (UK) Ltd | 390,600 | $32,775,000 | 2.80% |
Asymmetry Capital Management, L.P. | 25,918 | $2,175,000 | 2.14% |
Elk Creek Partners, LLC | 386,397 | $32,423,000 | 1.78% |
BB BIOTECH AG | 545,719 | $45,791,000 | 1.32% |
ALTRINSIC GLOBAL ADVISORS LLC | 383,166 | $32,151,000 | 1.27% |
DLD Asset Management, LP | 129,000 | $10,824,000 | 0.82% |
Opus Point Partners Management, LLC | 3,998 | $335,000 | 0.73% |
Virtus ETF Advisers LLC | 8,970 | $753,000 | 0.67% |